Accuracy of the Identification and Prognosis Prediction of SOFA-Based Sepsis-3 for Septic Patients in the Emergency Department Compared With Sepsis-2

与 Sepsis-2 相比,基于 SOFA 评分的 Sepsis-3 在急诊科脓毒症患者识别和预后预测方面的准确性。

阅读:1

Abstract

Aim: To evaluate the value of the Sequential Organ Failure Assessment (SOFA) score, a Sepsis-3 criterion, for identification and prognosis prediction among adult patients with sepsis in the emergency department (ED) compared with the Sepsis-2. Methods: Adult patients with suspected sepsis presenting to the ED were retrospectively identified via Sepsis-2/Sepsis-3 criteria. The vital signs, laboratory test results, etc., were collected, and the SOFA/quick SOFA (qSOFA) scores and National Early Warning Score (NEWS) were calculated accordingly. ROC curves were generated to evaluate mortality prediction accuracy. Results: Among the 481 patients included, 288/339 met the Sepsis-2/Sepsis-3 criteria, respectively, with moderate between-protocol consistency (Kappa = 0.507, p < 0.001; concordance = 77.3%); 115 patients (23.9%) died in hospital or within 28 days. SOFA/qSOFA scores and NEWS were significantly greater in the sepsis and death groups (p < 0.001), but there was no between-group difference for Sepsis-2/Sepsis-3. The temperature (T) and respiratory rate (RR) increased in the death group, whereas the systolic blood pressure (SBP) decreased. The usefulness of the SOFA score (AUC = 0.644) for predicting mortality was lower than that of qSOFA score (AUC = 0.716) and NEWS (AUC = 0.718), which could be improved (AUC = 0.701-0.721) by combining with two/three of variables (T, RR, and SBP). Conclusion: Compared with Sepsis-2, Sepsis-3 identified more patients with sepsis and was suitable for ED use. The SOFA score had lower mortality prediction accuracy than the qSOFA score and NEWS, which could be significantly improved by combining with two/three variables (T, RR, and SBP).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。